Antidiabetic sulphonylureas activate mitochondrial permeability transition in rat skeletal muscle

28Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Antidiabetic sulphonylureas can bind to various intracellular organelles including mitochondria. The aim of this study was to monitor the influence of antidiabetic sulphonylureas on membrane permeability in mitochondria isolated from rat skeletal muscle. The effects of glibenclamide (and other sulphonylurea derivatives) on mitochondrial function were studied by measuring mitochondrial swelling, mitochondrial membrane potential, respiration rate and Ca 2+ transport into mitochondria. We observed that glibenclamide induced mitochondrial swelling (EC 50 = 8.2±2.5 μM), decreased the mitochondrial membrane potential and evoked Ca 2+ efflux from the mitochondrial matrix. These effects were blocked by 2 μM cyclosporin A, an inhibitor of the mitochondrial permeability transition. Moreover, 30 μM glibenclamide accelerated the respiratory rate in the presence of glutamate/malate, substrates of complex I of the mitochondrial respiratory chain. In conclusion, we postulate that the antidiabetic sulphonylureas activate the mitochondrial permeability transition in skeletal muscle by increasing its sensitivity to Ca 2+. © 2005 Nature Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Skalska, J., Debska, G., Kunz, W. S., & Szewczyk, A. (2005). Antidiabetic sulphonylureas activate mitochondrial permeability transition in rat skeletal muscle. British Journal of Pharmacology, 145(6), 785–791. https://doi.org/10.1038/sj.bjp.0706214

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free